Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 4, 2025

Study Completion Date

August 4, 2025

Conditions
Myofascial Pain SyndromeTemporomandibular Joint DisordersFacial Pain
Interventions
PROCEDURE

Dry Needling

Dry needling applied to bilateral active trigger points in the masseter and temporalis muscles once per week for three weeks.

PROCEDURE

Lidocaine Hydrochloride

Lidocaine (20 mg/mL) injected into each active trigger point in the masseter and temporalis muscles once per week for three weeks.

PROCEDURE

Mepivacaine Hydrochloride

Mepivacaine (30 mg/mL) injected into each active trigger point in the masseter and temporalis muscles once per week for three weeks.

Trial Locations (1)

34083

Istanbul Medipol University, Faculty of Dentistry, Istanbul

All Listed Sponsors
lead

Sümer Münevveroğlu

OTHER

NCT07079449 - Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome | Biotech Hunter | Biotech Hunter